LILIYA SHIL: Open Payments
NPI 1578865432 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$951 in 15 payments from 8 companies in 2025. Trend: 2023 $605 · 2024 $564 · 2025 $951
Food & beverage: $951
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 3 | $450 |
| Intra-Sana Laboratories | 2 | $184 |
| Dexcom, Inc. | 1 | $110 |
| EMD Serono, Inc. | 3 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Forte Bio-Pharma LLC | 1 | $30 |
| ViiV Healthcare Company | 1 | $27 |
| ABBVIE INC. | 1 | $20 |
Products named: RECORLEV, RELTONE 200 MG, Dexcom G6 Transmitter, RELISTOR, PROLATE, DOVATO, UBRELVY.
Industry payments across NY — which companies pay providers there.
